Related Experiment Video

Updated: May 12, 2025

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
22:10

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit

Published on: June 28, 2013

13.1K

An overview of progress in human metapneumovirus (hMPV) research: Structure, function, and therapeutic opportunities

Nadine Krüger1, Stefan A Laufer2, Thanigaimalai Pillaiyar3

  • 1Platform Infection Models, German Primate Center, Leibniz Institute for Primate Research Göttingen 37077 Göttingen, Germany.

Drug Discovery Today
|April 26, 2025
PubMed

Insights

Human metapneumovirus (hMPV) causes severe respiratory illness globally, especially in young children. This review covers hMPV

Area of Science:

  • Virology
  • Infectious Diseases
  • Public Health

Background:

  • Human metapneumovirus (hMPV) is a significant respiratory pathogen.
  • It causes severe infections in vulnerable populations like infants, children, the elderly, and immunocompromised individuals.
  • hMPV is the second leading cause of pediatric bronchiolitis and pneumonia worldwide.

Purpose of the Study:

  • To review recent scientific advances and findings on hMPV.
  • To summarize the current literature on hMPV's life cycle, structure, and function.
  • To discuss current prevention and treatment strategies for hMPV infections.

Main Methods:

  • Literature review of current scientific findings on hMPV.
  • Synthesis of information on hMPV's biological characteristics.
  • Analysis of existing data on hMPV prevention and treatment.

Main Results:

  • hMPV poses a substantial global health burden, particularly in young children.
  • There is a lack of specific antiviral therapies and vaccines for hMPV.
  • Recent research has expanded understanding of hMPV's biology and epidemiology.

Conclusions:

  • Effective prevention and treatment options for hMPV are urgently needed.
  • Further research into hMPV is critical to mitigate its impact on public health.
  • Addressing the hMPV challenge requires a multi-faceted approach including vaccine and antiviral development.
Keywords:
F protein inhibitorsantiviralsdrug repurposinghuman metapneumovirus (hMPV)small moleculesvaccinesviral outbreak

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.6K
Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

14.8K

Related Concept Videos

Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.0K